Guidance on instructing patients, treatment selection, impact of disease course and more
Who is at risk? What tests should be ordered?
Guidance for the 5% to 20% of patients with suboptimal response or tolerability
Diagnostic and therapeutic advancements have significantly curbed disease gravity
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
From gene therapy for SMA to headache advances, big things are afoot in our field